Does Inositol Cause Weight Gain? What the Trials Measured

Does Inositol Cause Weight Gain?

No published trial has reported weight gain as an effect of inositol. Myo-inositol works as a second-messenger inside the insulin-signalling pathway — it helps cells respond to the insulin a person already produces — and nothing in that mechanism stores fat, increases appetite, or slows metabolism. A meta-analysis of 9 randomised trials and 496 women found myo-inositol significantly reduced fasting insulin and the HOMA insulin-resistance index, the pathway inositol is actually documented to act on — not appetite or fat storage. Every controlled trial measuring body weight or BMI on inositol found it unchanged or modestly reduced, never increased — which answers the reverse framing of this same question just as directly. Whether you arrived asking about gain or about myo-inositol weight loss, the trial data is the same data, and it moves in one direction only: down, and only slightly.

You may see PCOS increasingly written as polyendocrine metabolic ovarian syndrome (PMOS), the name a May 2026 global consensus of more than 50 organisations gave the same condition. None of the weight data below changed with the rename; this article uses PCOS because that is still what most readers search.

What Do the Weight Trials Actually Show?

Fifteen controlled trials pooled into one meta-analysis found inositol supplementation significantly reduced BMI by an average of 0.41 kg/m² (95% CI −0.78 to −0.04, p=0.028) across adult participants — a small effect, not a dramatic one, and one measured across trials that varied in dose, duration and inositol type. That variation mattered: the reduction was more clinically significant specifically in participants who had both PCOS and overweight or obesity, and myo-inositol on its own produced a stronger BMI effect than other inositol forms tested.

Myo-Inositol for PCOS Weight Loss: Does It Depend on Your Starting Weight?

Starting BMI is the variable that decided the outcome in the trials above, not the dose or the brand. In a 2024 randomised trial restricted to 60 normal-weight women with PCOS and insulin resistance, BMI showed no significant difference between the myo-inositol group and the metformin group before or after 6 to 8 months of treatment — both groups’ insulin resistance and androgen markers improved similarly, but neither drug moved the scale in women who did not carry extra weight to begin with. That is the honest answer to “inositol for PCOS weight loss”: if you are lean PCOS, the trial evidence does not support expecting a weight change from inositol either direction, because the mechanism it acts on — insulin sensitivity — has less room to move when insulin resistance is not driving your weight picture.

A broader systematic review of 30 trials commissioned to inform the 2023 international PCOS guideline update reached a similarly measured conclusion: metformin may improve waist-to-hip ratio more than inositol in head-to-head comparisons, and the review rated the overall evidence for inositol in PCOS as limited and inconclusive. That is not a reason to dismiss inositol — its insulin and androgen effects are separately documented — but it is a reason not to expect it to outperform a licensed medication on anthropometric measures.

Why Might You Feel Like You’re Gaining Weight on Inositol?

Nothing in the trial evidence above identifies a mechanism by which inositol adds body fat, so a perceived gain after starting it is more likely explained by something running alongside it than by the supplement itself. A few possibilities worth checking, in roughly the order they are easiest to rule out:

• Water retention or normal cycle-to-cycle fluctuation. Weight can shift 1–2 kg day to day for reasons that have nothing to do with any supplement, inositol included.
• A powder formulation with added ingredients. Some inositol powders are blended with sweeteners, flavourings or additional compounds that were not part of the plain myo-inositol dosed in the trials above — check the label against what you are actually measuring against.
• A coinciding change elsewhere — a new medication, a change in activity, a stressful period, or simply the underlying condition continuing on its own course while you started a supplement at the same time.
• An unrelated cause worth a clinician’s attention, including thyroid function, which shares symptom overlap with PCOS and is worth ruling out rather than assuming.

None of these is a documented inositol side effect — they are the more statistically likely explanations, because no trial measuring inositol against placebo or metformin has ever reported weight gain in the treatment group.

Does the Myo-Inositol to D-Chiro-Inositol Ratio Change This?

Form matters more than dose here: the pooled analysis found myo-inositol alone produced a stronger BMI effect than other inositol types tested, which is one more reason the specific compound and ratio you’re taking is worth checking before assuming a formulation problem is a weight problem. Most PCOS-specific trials, including the insulin and androgen data reviewed in the broader inositol evidence base, used myo-inositol alone or myo- and D-chiro-inositol together at the studied 40:1 ratio — not the reverse ratios or D-chiro-dominant blends sold under some “PCOS support” labels.

How Long Before Any Weight-Related Change Would Show Up?

Twelve to twenty-four weeks is the range across which the trials above actually measured body composition — there is no data point earlier than that, and none confirms what changes, if anything, past six months. The Gudović 2024 trial ran 6 to 8 months and still found no BMI difference in normal-weight women; the pooled meta-analysis drew its 0.41 kg/m² average from trials of varying length, with duration itself listed as a source of the result’s variability. Expecting a visible change inside a few weeks outruns what any of this evidence supports.

Who Inositol Is Not a Weight Tool For

Inositol has not been shown to produce meaningful weight loss in normal-weight women with PCOS — the 2024 head-to-head trial above found no BMI difference from metformin in that group over eight months, so starting inositol specifically expecting the scale to move if you are not carrying insulin-resistance-driven weight is not what the evidence supports. It is also the wrong tool if you are looking for a fast result: the meta-analysis effect size is small and pooled across trials lasting months, not weeks. And it is not a substitute for investigating other, unrelated causes of weight change — thyroid disease, medication side effects, and the underlying condition’s own course all move the number on the scale independently of any supplement, which is also worth ruling out before assuming the supplement itself has stopped doing its job.

Your Next Step

If weight change is what brought you here, track it alongside your ovulation and insulin markers for a few cycles rather than in isolation — the trial evidence above ties inositol’s weight effect, such as it is, to insulin resistance improving, not to inositol acting on weight directly. The rest of the supplements and medications section covers the other insulin-sensitising options this evidence base gets compared against. If inositol has not been doing what you expected more broadly, or you’re weighing it against another option entirely, the inositol vs berberine comparison covers a supplement with a very different mechanism and a very different risk profile.